CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Qomel Co is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Qomel Co
Phone: +966 112886660p:+966 112886660 RIYADH, 11445  Saudi Arabia Ticker: 96009600

Business Summary
Qomel Company is a Saudi Arabia-based entity which primarily engaged in providing health care services. The Company is also engaged in pharmaceutical preparations manufacturing. The Company's services include general medical services and specialized services, medicines and medical services to patients, diagnostic services, and medical equipment, and materials supplies. The Company has branches in Jeddah, along the Red Sea, and Dammam, at the Arabian Gulf.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

General Information
Outstanding Shares: 3,500,000 (As of 6/30/2024)
Stock Exchange: SAU
Email Address: info@qomenl.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024